AgThera discovers a new class of antibacterial and antiviral living medicines for infectious diseases. With synthetic biology techniques we engineer hundreds of variant antimicrobial probiotics. With computational biology and machine learning we can guide engineering of these live biotherapeutics, analyze the results of experiments and design new systems for high performance. AgThera's live therapeutics are tailored to eliminate pathogens effectively and reliably.